Aura Biosciences Stock Market Value
| AURA Stock | USD 8.73 0.16 1.80% |
| Symbol | Aura |
Aura Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aura Biosciences. If investors know Aura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aura Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Return On Assets (0.30) | Return On Equity (0.51) |
The market value of Aura Biosciences is measured differently than its book value, which is the value of Aura that is recorded on the company's balance sheet. Investors also form their own opinion of Aura Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aura Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aura Biosciences' market value can be influenced by many factors that don't directly affect Aura Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aura Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aura Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aura Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aura Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aura Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aura Biosciences.
| 12/28/2022 |
| 12/17/2024 |
If you would invest 0.00 in Aura Biosciences on December 28, 2022 and sell it all today you would earn a total of 0.00 from holding Aura Biosciences or generate 0.0% return on investment in Aura Biosciences over 720 days. Aura Biosciences is related to or competes with Aerovate Therapeutics, Adagene, Acrivon Therapeutics,, Rezolute, AN2 Therapeutics, Seer, and Oric Pharmaceuticals. Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer More
Aura Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aura Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aura Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 19.67 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 6.9 |
Aura Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aura Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aura Biosciences' standard deviation. In reality, there are many statistical measures that can use Aura Biosciences historical prices to predict the future Aura Biosciences' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.08) |
Aura Biosciences Backtested Returns
Aura Biosciences secures Sharpe Ratio (or Efficiency) of -0.0145, which signifies that the company had a -0.0145% return per unit of risk over the last 3 months. Aura Biosciences exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aura Biosciences' Risk Adjusted Performance of (0.02), mean deviation of 2.54, and Standard Deviation of 3.54 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.82, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aura Biosciences will likely underperform. At this point, Aura Biosciences has a negative expected return of -0.0521%. Please make sure to confirm Aura Biosciences' kurtosis, and the relationship between the treynor ratio and day median price , to decide if Aura Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.44 |
Modest reverse predictability
Aura Biosciences has modest reverse predictability. Overlapping area represents the amount of predictability between Aura Biosciences time series from 28th of December 2022 to 23rd of December 2023 and 23rd of December 2023 to 17th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aura Biosciences price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Aura Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 1.19 |
Aura Biosciences lagged returns against current returns
Autocorrelation, which is Aura Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aura Biosciences' stock expected returns. We can calculate the autocorrelation of Aura Biosciences returns to help us make a trade decision. For example, suppose you find that Aura Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aura Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aura Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aura Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aura Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Aura Biosciences Lagged Returns
When evaluating Aura Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aura Biosciences stock have on its future price. Aura Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aura Biosciences autocorrelation shows the relationship between Aura Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Aura Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aura Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aura Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aura Biosciences Stock:Check out Aura Biosciences Correlation, Aura Biosciences Volatility and Aura Biosciences Alpha and Beta module to complement your research on Aura Biosciences. For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Aura Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.